Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

HRES 1079 is a non-binding House resolution recognizing Charcot-Marie-Tooth disease (CMT) as a significant health condition affecting approximately 126,000 people in the U.S. and millions globally. It expresses the House’s support for increased federal funding for CMT research at the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH). The resolution specifically highlights that CMT research funding decreased in 2022 compared to 2021 and emphasizes the need for sustained investment in studying this inherited nerve disorder, which currently has no cure. As a recognition resolution, it does not allocate funds but formally urges continued NIH support for CMT and rare disease research.